Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE-2: Sorafenib + TACE in HCC
NCT01324076Phase 3Unknown
- Sponsor
- University College London
- Start
- Nov 2010
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by University College London. Status: unknown.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01324076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01324076.